Tandem Diabetes Care Inc (TNDM) support and resistance · rev $501.8M
Tandem Diabetes Care Inc (TNDM) is a medical devices company listed on NASDAQ.
This page maps Tandem Diabetes Care Inc (TNDM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TNDM revenue for 2026-06-30 was $501.8M. Net income was -$41.6M. TNDM currently screens at market cap $1.06B.
TNDM currently screens at market cap $1.06B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TNDM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TNDM quote page for the session range and the stock page for the full model.
Not investment advice.